
Sign up to save your podcasts
Or


Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719
By Michael Putman4.9
114114 ratings
Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719

506 Listeners

299 Listeners

124 Listeners

3,360 Listeners

1,152 Listeners

120 Listeners

197 Listeners

517 Listeners

68 Listeners

4 Listeners

373 Listeners

182 Listeners

188 Listeners

17 Listeners

6 Listeners